Mirtazapine Tablet, Film Coated
Product Images NDC 0615-8489

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 0615-8489). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Mirtazapine Tabs 8489 1)

Chemical structure of mirtazapine, depicting its fused multi-ring system including nitrogen atoms and a methyl group attached to the structure.*

FDA Label Image

Principal Display Panel (Mirtazapine Tabs 8489 2)

Mirtazapine Tablets USP 7.5 mg label for oral use by NCS HealthCare of KY, LLC dba Vangard Labs. The label displays lot number 8489, quantity 30 tablets, storage instructions at 20°-25°C in a light-resistant container, and the product NDC 0615-8489. It includes multiple small barcode labels for institutional use and mentions packaging by Vanguard in Glasgow, KY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.